Antiviral Use in Canadian Children Hospitalized for Influenza

Author:

Mehta Kayur1,Morris Shaun K.2,Bettinger Julie A3,Vaudry Wendy4,Jadavji Taj5,Halperin Scott A.6,Bancej Christina7,Sadarangani Manish38,Dendukuri Nandini19,Papenburg Jesse110119

Affiliation:

1. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada

2. Division of Pediatric Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

3. Vaccine Evaluation Center, British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia, Canada

4. Division of Pediatric Infectious Diseases, Department of Paediatrics, Stollery Children’s Hospital, University of Alberta, Edmonton, Alberta, Canada

5. Section of Infectious Diseases, Department of Paediatrics, Alberta Children’s Hospital, University of Calgary, Calgary, Alberta, Canada

6. Canadian Center for Vaccinology, IWK Health Center, Dalhousie University, Halifax, Nova Scotia, Canada

7. Center for Immunization & Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, Canada

8. Department of Pediatrics, University of British Columbia, British Columbia, Canada

9. Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

10. Division of Pediatric Infectious Diseases, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Centre, Montreal, Quebec, Canada

11. Division of Microbiology, Department of Clinical Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada

Abstract

OBJECTIVES Antivirals are recommended for children hospitalized with influenza but are underutilized. We describe antiviral prescribing during influenza admissions in Canadian pediatric centers and identify factors associated with antiviral use. METHODS We performed active surveillance for laboratory-confirmed influenza hospitalizations among children ≤16 years old at the 12 Canadian Immunization Monitoring Program Active hospitals, from 2010–2011 to 2018–2019. Logistic regression analyses were used to identify factors associated with antiviral use. RESULTS Among 7545 patients, 57.4% were male; median age was 3 years (interquartile range: 1.1–6.3). Overall, 41.3% received antiviral agents; 72.8% received antibiotics. Antiviral use varied across sites (range, 10.2% to 81.1%) and influenza season (range, 19.9% to 59.6%) and was more frequent in children with ≥1 chronic health condition (52.7% vs 36.7%; P < .001). On multivariable analysis, factors associated with antiviral use included older age (adjusted odds ratio [aOR] 1.04 [95% confidence interval (CI), 1.02–1.05]), more recent season (highest aOR 9.18 [95% CI, 6.70–12.57] for 2018–2019), admission during peak influenza period (aOR 1.37 [95% CI, 1.19–1.58]), availability of local treatment guideline (aOR 1.54 [95% CI, 1.17–2.02]), timing of laboratory confirmation (highest aOR 2.67 [95% CI, 1.97–3.61] for result available before admission), presence of chronic health conditions (highest aOR 4.81 [95% CI, 3.61–6.40] for cancer), radiographically confirmed pneumonia (aOR 1.39 [95% CI, 1.20–1.60]), antibiotic treatment (aOR 1.51 [95% CI, 1.30–1.76]), respiratory support (1.57 [95% CI, 1.19–2.08]), and ICU admission (aOR 3.62 [95% CI, 2.88–4.56]). CONCLUSIONS Influenza antiviral agents were underused in Canadian pediatric hospitals, including among children with high-risk chronic health conditions. Prescribing varied considerably across sites, increased over time, and was associated with patient and hospital-level characteristics. Multifaceted hospital-based interventions are warranted to strengthen adherence to influenza treatment guidelines and antimicrobial stewardship practices.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Reference50 articles.

1. Global role and burden of influenza in pediatric respiratory hospitalizations, 1982-2012: a systematic analysis;Lafond;PLoS Med,2016

2. Estimating influenza disease burden from population-based surveillance data in the United States;Reed;PLoS One,2015

3. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness;Rolfes;Influenza Other Respir Viruses,2018

4. Centers for Disease Control and Prevention . Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States — 2019–2020 influenza season. Available at https://www.cdc.gov/flu/about/burden/2019-2020.html#:∼:text=CDC%20estimates%20that%20the%20burden,flu%20deaths%20(Table%201) Accessed July 14, 2021

5. Burden of influenza, respiratory syncytial virus, and other respiratory viruses and the completeness of respiratory viral identification among respiratory inpatients, Canada, 2003-2014;Schanzer;Influenza Other Respir Viruses,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3